Sue Bell

47.1k total citations · 1 hit paper
70 papers, 4.3k citations indexed

About

Sue Bell is a scholar working on Oncology, Hematology and Molecular Biology. According to data from OpenAlex, Sue Bell has authored 70 papers receiving a total of 4.3k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Oncology, 28 papers in Hematology and 20 papers in Molecular Biology. Recurrent topics in Sue Bell's work include Multiple Myeloma Research and Treatments (28 papers), Cancer Treatment and Pharmacology (13 papers) and Protein Degradation and Inhibitors (12 papers). Sue Bell is often cited by papers focused on Multiple Myeloma Research and Treatments (28 papers), Cancer Treatment and Pharmacology (13 papers) and Protein Degradation and Inhibitors (12 papers). Sue Bell collaborates with scholars based in United Kingdom, United States and Australia. Sue Bell's co-authors include Gareth J. Morgan, Faith E. Davies, Mark T. Drayson, Roger G. Owen, J. A. Child, Julia Brown, Peter J. Selby, Kim Hawkins, Graham Jackson and Walter M. Gregory and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Journal of Clinical Oncology.

In The Last Decade

Sue Bell

68 papers receiving 4.2k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

High-Dose Chemotherapy with Hematopoietic Stem-Cell Rescue for Multiple Myeloma

2003 1.3k citations J. A. Child, Gareth J. Morgan et al. New England Journal of Medicine profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Sue Bell	3.1k	2.3k	2.1k	392	214	70	4.3k
Zhinuan Yu	3.9k 1.2×	3.1k 1.4×	2.5k 1.2×	515 1.3×	98 0.5×	52	4.4k
Fiona M. Ross	2.6k 0.8×	2.7k 1.2×	1.2k 0.6×	808 2.1×	80 0.4×	84	4.5k
Rafat Abonour	2.6k 0.8×	2.1k 0.9×	1.9k 0.9×	576 1.5×	715 3.3×	192	4.5k
Bart Burington	1.1k 0.3×	1.2k 0.5×	513 0.2×	255 0.7×	55 0.3×	31	2.2k
Cornelius F. Waller	623 0.2×	867 0.4×	1.0k 0.5×	612 1.6×	399 1.9×	158	3.2k
Larry D. Cripe	1.8k 0.6×	1.3k 0.6×	1.1k 0.5×	1.4k 3.4×	61 0.3×	104	4.2k
C. Michel Zwaan	2.1k 0.7×	1.7k 0.7×	608 0.3×	401 1.0×	177 0.8×	152	3.9k
Alexander Gaiger	872 0.3×	957 0.4×	710 0.3×	764 1.9×	114 0.5×	70	2.8k
James M. Foran	2.0k 0.6×	1.2k 0.5×	2.0k 0.9×	1.7k 4.3×	95 0.4×	243	5.4k
Joachim Beck	1.1k 0.4×	913 0.4×	832 0.4×	277 0.7×	44 0.2×	35	2.5k

Countries citing papers authored by Sue Bell

Since Specialization

Citations

This map shows the geographic impact of Sue Bell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sue Bell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sue Bell more than expected).

Fields of papers citing papers by Sue Bell

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sue Bell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sue Bell. The network helps show where Sue Bell may publish in the future.

Co-authorship network of co-authors of Sue Bell

This figure shows the co-authorship network connecting the top 25 collaborators of Sue Bell. A scholar is included among the top collaborators of Sue Bell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sue Bell. Sue Bell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Rawstron, Andy C., David Cairns, Nichola Webster, et al.. (2025). Optimising MRD-guided treatment: UMRD4 as a half-way treatment timepoint for ibrutinib-venetoclax substantially delays MRD relapse after end of treatment in both IGHV-mutated and IGHV-unmutated CLL.. Blood. 146(Supplement 1). 794–794.

Corrie, Pippa, Helen Marshall, Ruth Plummer, et al.. (2021). The DANTE trial protocol: a randomised phase III trial to evaluate the Duration of ANti-PD-1 monoclonal antibody Treatment in patients with metastatic mElanoma. BMC Cancer. 21(1). 761–761. 18 indexed citations

Wakeham, Katie, Louise Murray, R. Muirhead, et al.. (2021). Multicentre Investigation of Prognostic Factors Incorporating p16 and Tumour Infiltrating Lymphocytes for Anal Cancer After Chemoradiotherapy. Clinical Oncology. 33(10). 638–649. 8 indexed citations

Danson, Sarah, et al.. (2019). Are we over-treating with checkpoint inhibitors?. British Journal of Cancer. 121(8). 629–630. 13 indexed citations

Franks, K., Lucy McParland, David Baldwin, et al.. (2018). P2.16-16 SABRTOOTH: A Fasibility Study of SABR Versus Surgery in Patients with Peripheral Stage I NSCLC Considered to be at Higher Risk for Surgery. Journal of Thoracic Oncology. 13(10). S837–S837. 1 indexed citations

Sams, Craig, Kate Jones, Nicholas Warren, et al.. (2015). Towards a biological monitoring guidance value for acrylamide. Toxicology Letters. 237(1). 30–37. 15 indexed citations

Morgan, Gareth J., Graham Jackson, Faith E. Davies, et al.. (2012). Efficacy and side-effect profile of long-term bisphosphonate therapy in patients (pts) with multiple myeloma (MM): MRC myeloma IX study results.. Journal of Clinical Oncology. 30(15_suppl). 8015–8015. 1 indexed citations

Morgan, Gareth J., Faith E. Davies, Walter M. Gregory, et al.. (2011). Cyclophosphamide, thalidomide, and dexamethasone as induction therapy for newly diagnosed multiple myeloma patients destined for autologous stem-cell transplantation: MRC Myeloma IX randomized trial results. Haematologica. 97(3). 442–450. 114 indexed citations

Boyd, Kevin, F. M. Ross, Laura Chiecchio, et al.. (2011). A novel prognostic model in myeloma based on co-segregating adverse FISH lesions and the ISS: analysis of patients treated in the MRC Myeloma IX trial. Leukemia. 26(2). 349–355. 224 indexed citations

10.

Morgan, Gareth J., Faith E. Davies, Walter M. Gregory, et al.. (2010). First-line treatment with zoledronic acid as compared with clodronic acid in multiple myeloma (MRC Myeloma IX): a randomised controlled trial. The Lancet. 376(9757). 1989–1999. 407 indexed citations

11.

Bifulco, Carlo, et al.. (2008). Genotypic Analysis of Hydatidiform Mole: An Accurate and Practical Method of Diagnosis. The American Journal of Surgical Pathology. 32(3). 445–451. 64 indexed citations

12.

Bell, Sue. (2005). Current Issues and Challenges in the Management of Bariatric Patients. Journal of Wound Ostomy and Continence Nursing. 32(6). 386–392. 4 indexed citations

13.

Morgan, Gareth J., Faith E. Davies, Kim Hawkins, et al.. (2004). Follow up Analysis for MRC Myeloma VII Trial.. Blood. 104(11). 927–927. 2 indexed citations

14.

Carr, Daniel B., et al.. (2003). The State Cancer Profiles web site and extensions of linked micromap plots and conditioned choropleth map plots. International Conference on Digital Government Research. 1–5. 5 indexed citations

15.

Child, J. A., Gareth J. Morgan, Faith E. Davies, et al.. (2003). High-Dose Chemotherapy with Hematopoietic Stem-Cell Rescue for Multiple Myeloma. New England Journal of Medicine. 348(19). 1875–1883. 1348 indexed citations breakdown →

16.

Phekoo, Karen, Henrik Møller, David Bevan, Sue Bell, & Steve Schey. (2002). Engaging clinicians with a cancer registry improves ascertainment rates in haematological malignancies.. Blood. 100(11). 1 indexed citations

17.

Black, Donald W., et al.. (1997). Predictors of long-term outcome in 45 men with antisocial personality disorder.. Annals of Clinical Psychiatry. 9(4). 211–217. 13 indexed citations

18.

Bell, Sue, Louise Parker, Michael Cole, & Alan Craft. (1994). Screening Infants For Neuroblastoma: The Parents' Perspective. Pediatric Hematology and Oncology. 11(4). 433–437. 6 indexed citations

19.

Black, Donald W., et al.. (1992). Depression and other mental disorders in the relatives of morbidly obese patients. Journal of Affective Disorders. 25(2). 91–95. 26 indexed citations

20.

Bell, Sue. (1991). Screening babies for neuroblastoma.. PubMed. 64(2). 47–9. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact